Constellation Brands (STZ) 10-Q3 Jul 242025 Q1 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	3 Months Ended
Cover Page - shares	May 31, 2024	Jun. 28, 2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	May 31, 2024
Document Transition Report	false
Entity File Number	001-08495
Entity Registrant Name	CONSTELLATION BRANDS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	16-0716709
Entity Address, Address Line One	50 East Broad Street
Entity Address, City or Town	Rochester
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	14614
City Area Code	585
Local Phone Number	678-7100
Title of 12(b) Security	Class A Common Stock
Trading Symbol	STZ
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000016918
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--02-28
Class A Stock
Entity Common Stock, Shares Outstanding		182,192,431
Class 1 Common Stock
Entity Common Stock, Shares Outstanding		25,541

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024
Current assets:
Cash and cash equivalents	$ 73.8	$ 152.4
Accounts receivable	893.9	832.8
Inventories	2,127	2,078.3
Prepaid expenses and other	733.7	666
Total current assets	3,828.4	3,729.5
Property, plant, and equipment	8,298	8,055.2
Goodwill	7,985.4	7,980.3
Intangible assets	2,731.5	2,731.7
Deferred income taxes	2,020.3	2,055
Other assets	1,196.5	1,140
Total assets	26,060.1	25,691.7
Current liabilities:
Short-term borrowings	793.2	241.4
Current maturities of long-term debt	406.2	956.8
Accounts payable	1,139.3	1,107.1
Other accrued expenses and liabilities	783.5	836.4
Total current liabilities	3,122.2	3,141.7
Long-term debt, less current maturities	10,682.9	10,681.1
Deferred income taxes and other liabilities	1,683.1	1,804.3
Total liabilities	15,488.2	15,627.1
Commitments and contingencies
CBI stockholders’ equity:
Additional paid-in capital	2,070.3	2,047.3
Retained earnings	14,109.5	13,417.2
Accumulated other comprehensive income (loss)	367.8	376.8
Total CBI stockholders’ equity	10,251.8	9,743.1
Noncontrolling interests	320.1	321.5
Total stockholders’ equity	10,571.9	10,064.6
Total liabilities and stockholders’ equity	26,060.1	25,691.7
Class A Stock
CBI stockholders’ equity:
Common stock, value	2.1	2.1
Class A Stock in treasury	$ (6,297.9)	$ (6,100.3)

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - Class A Stock - $ / shares	May 31, 2024	Feb. 29, 2024
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	322,000,000	322,000,000
Common stock, shares issued (in shares)	212,698,298	212,698,298
Treasury stock, at cost (in shares)	30,341,484	29,809,881

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	May 31, 2024	May 31, 2023
Sales	$ 2,860.7	$ 2,699.5
Excise taxes	(198.9)	(184.6)
Net sales	2,661.8	2,514.9
Cost of product sold	(1,258)	(1,257.1)
Gross profit	1,403.8	1,257.8
Selling, general, and administrative expenses	(462.2)	(493.1)
Operating income (loss)	941.6	764.7
Income (loss) from unconsolidated investments	82	(415.4)
Interest expense, net	(102.8)	(118.9)
Income (loss) before income taxes	920.8	230.4
(Provision for) benefit from income taxes	(28)	(91.2)
Net income (loss)	892.8	139.2
Net (income) loss attributable to noncontrolling interests	(15.8)	(3.3)
Net income (loss) attributable to CBI	877	135.9
Comprehensive income (loss)	884.1	364.5
Comprehensive (income) loss attributable to noncontrolling interests	(16.1)	(14.2)
Comprehensive income (loss) attributable to CBI	868	350.3
Class A Stock
Net income (loss) attributable to CBI	$ 877	$ 135.9
Class A Stock:
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 4.80	$ 0.74
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 4.78	$ 0.74
Weighted average common shares outstanding - basic (in shares)	182,766	183,270
Weighted average common shares outstanding - diluted (in shares)	183,461	183,863
Cash dividends declared per common share (in dollars per share)	$ 1.01	$ 0.89

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Millions	Total	Class A Stock	Common Stock Class A Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Non-controlling Interests
Stockholders' equity, beginning of period at Feb. 28, 2023	$ 8,733.9		$ 2.1	$ 1,903	$ 12,343.9	$ 28.5	$ (5,863.9)	$ 320.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	139.2				135.9			3.3
Other comprehensive income (loss), net of income tax effect	225.3					214.4		10.9
Comprehensive income (loss)	364.5
Repurchase of shares	(35)						(35)
Dividends declared	(163.1)				(163.1)
Non-controlling interest distributions	(11.3)							(11.3)
Shares issued under equity compensation plans	4.7			0.6			4.1
Stock-based compensation	14.5			14.5
Stockholders' equity, end of period at May. 31, 2023	8,908.2		2.1	1,918.1	12,316.7	242.9	(5,894.8)	323.2
Stockholders' equity, beginning of period at Feb. 29, 2024	10,064.6		2.1	2,047.3	13,417.2	376.8	(6,100.3)	321.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	892.8				877			15.8
Other comprehensive income (loss), net of income tax effect	(8.7)					(9)		0.3
Comprehensive income (loss)	884.1
Repurchase of shares	(200)	$ (200)					(200)
Dividends declared	(184.7)				(184.7)
Non-controlling interest distributions	(17.5)							(17.5)
Shares issued under equity compensation plans	8.1			5.7			2.4
Stock-based compensation	17.3			17.3
Stockholders' equity, end of period at May. 31, 2024	$ 10,571.9		$ 2.1	$ 2,070.3	$ 14,109.5	$ 367.8	$ (6,297.9)	$ 320.1

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	May 31, 2024	May 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 892.8	$ 139.2
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Unrealized net (gain) loss on securities measured at fair value	0	71.8
Deferred tax provision (benefit)	25	(0.3)
Depreciation	111.6	105.3
Stock-based compensation	17.3	14.5
Equity in (earnings) losses of equity method investees and related activities, net of distributed earnings	1.3	220.6
Noncash lease expense	29.1	22
Impairment of equity method investments	0	123.5
Net gain on conversion and exchange to Exchangeable Shares	(83.3)	0
Change in operating assets and liabilities, net of effects from purchase and sale of business:
Accounts receivable	(63.4)	(31.5)
Inventories	(47.3)	(57.6)
Prepaid expenses and other current assets	(61.4)	(17.9)
Accounts payable	62.7	34.2
Deferred revenue	15.6	24.3
Other accrued expenses and liabilities	(97.7)	(73.2)
Other	(111.8)	90.5
Total adjustments	(202.3)	526.2
Net cash provided by (used in) operating activities	690.5	665.4
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant, and equipment	(375.3)	(277)
Investments in equity method investees and securities	(13)	(21.6)
Proceeds from sale of assets	12.9	0
Proceeds from sale of business	0	6.7
Other investing activities	(2)	0
Net cash provided by (used in) investing activities	(377.4)	(291.9)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of long-term debt	0	744.8
Principal payments of long-term debt	(552.2)	(502.5)
Net proceeds from (repayments of) short-term borrowings	551.8	(346.3)
Dividends paid	(185.3)	(164.1)
Purchases of treasury stock	(200)	(35)
Proceeds from shares issued under equity compensation plans	24.7	15.9
Payments of minimum tax withholdings on stock-based payment awards	(13.8)	(11.2)
Payments of debt issuance, debt extinguishment, and other financing costs	0	(5)
Distributions to noncontrolling interests	(17.5)	(11.3)
Payment of contingent consideration	(0.7)	0
Net cash provided by (used in) financing activities	(393)	(314.7)
Effect of exchange rate changes on cash and cash equivalents	1.3	0.2
Net increase (decrease) in cash and cash equivalents	(78.6)	59
Cash and cash equivalents, beginning of period	152.4	133.5
Cash and cash equivalents, end of period	73.8	192.5
Supplemental disclosures of noncash investing and financing activities
Additions to property, plant, and equipment	$ 195.2	$ 142.2

Basis of Presentation

Basis of Presentation	3 Months Ended
Basis of Presentation	May 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION We have prepared the Financial Statements, without audit, pursuant to the rules and regulations of the SEC applicable to quarterly reporting on Form 10-Q and reflect, in our opinion, all adjustments necessary to present fairly our financial information. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements, prepared in accordance with generally accepted accounting principles, have been condensed or omitted as permitted by such rules and regulations. These Financial Statements should be read in conjunction with the consolidated financial statements and related notes included in the 2024 Annual Report. Results of operations for interim periods are not necessarily indicative of annual results. Reclassification We reclassified equity method investments to other assets on our consolidated balance sheet as of February 29, 2024, to conform with current year presentation.

Inventories

Inventories	3 Months Ended
Inventories	May 31, 2024
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories are stated at the lower of cost (primarily computed in accordance with the first-in, first-out method) or net realizable value. Elements of cost include materials, labor, and overhead and consist of the following: May 31, February 29, (in millions) Raw materials and supplies $ 244.1 $ 254.1 In-process inventories 1,109.5 1,096.0 Finished case goods 773.4 728.2 $ 2,127.0 $ 2,078.3

Derivative Instruments

Derivative Instruments	3 Months Ended
Derivative Instruments	May 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS Overview Our risk management and derivative accounting policies are presented in Notes 1 and 6 of our consolidated financial statements included in our 2024 Annual Report and have not changed significantly for the three months ended May 31, 2024. The aggregate notional value of outstanding derivative instruments is as follows: May 31, February 29, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts $ 2,083.1 $ 2,045.6 Derivative instruments not designated as hedging instruments Foreign currency contracts $ 829.5 $ 735.9 Commodity derivative contracts $ 351.5 $ 397.5 Credit risk We are exposed to credit-related losses if the counterparties to our derivative contracts default. This credit risk is limited to the fair value of the derivative contracts. To manage this risk, we contract only with major financial institutions that have earned investment-grade credit ratings and with whom we have standard International Swaps and Derivatives Association agreements which allow for net settlement of the derivative contracts. We have also established counterparty credit guidelines that are regularly monitored. Because of these safeguards, we believe the risk of loss from counterparty default to be immaterial. In addition, our derivative instruments are not subject to credit rating contingencies or collateral requirements. As of May 31, 2024, the estimated fair value of derivative instruments in a net liability position due to counterparties was $2.2 million. If we were required to settle the net liability position under these derivative instruments on May 31, 2024, we would have had sufficient available liquidity on hand to satisfy this obligation. Results of period derivative activity The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 4): Assets Liabilities May 31, February 29, May 31, February 29, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 148.0 $ 154.1 Other accrued expenses and liabilities $ 2.5 $ 3.5 Other assets $ 141.0 $ 153.5 Deferred income taxes and other liabilities $ 0.5 $ 0.2 Derivative instruments not designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 2.7 $ 3.6 Other accrued expenses and liabilities $ 3.8 $ 1.7 Commodity derivative contracts: Prepaid expenses and other $ 11.2 $ 4.8 Other accrued expenses and liabilities $ 19.1 $ 27.9 Other assets $ 5.7 $ 1.4 Deferred income taxes and other liabilities $ 4.5 $ 8.1 The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows: Derivative Instruments in Net Location of Net Gain (Loss) Net (in millions) For the Three Months Ended May 31, 2024 Foreign currency contracts $ 26.1 Sales $ 0.1 Cost of product sold 39.1 $ 26.1 $ 39.2 For the Three Months Ended May 31, 2023 Foreign currency contracts $ 79.3 Sales $ — Cost of product sold 26.4 Pre-issuance hedge contracts 0.6 Interest expense, net (0.2) $ 79.9 $ 26.2 We expect $128.3 million of net gains, net of income tax effect, to be reclassified from AOCI to our results of operations within the next 12 months. The effect of our undesignated derivative instruments on our results of operations is as follows: Derivative Instruments Not Location of Net Gain (Loss) Net (in millions) For the Three Months Ended May 31, 2024 Commodity derivative contracts Cost of product sold $ 14.6 Foreign currency contracts Selling, general, and administrative expenses 4.0 $ 18.6 For the Three Months Ended May 31, 2023 Commodity derivative contracts Cost of product sold $ (34.7) Foreign currency contracts Selling, general, and administrative expenses 12.7 $ (22.0)

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
Fair Value of Financial Instruments	May 31, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE OF FINANCIAL INSTRUMENTS	FAIR VALUE OF FINANCIAL INSTRUMENTS Authoritative guidance establishes a framework for measuring fair value, including a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy includes three levels: • Level 1 inputs are quoted prices in active markets for identical assets or liabilities; • Level 2 inputs include data points that are observable such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) such as volatility, interest rates, and yield curves that are observable for the asset or liability, either directly or indirectly; and • Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. Fair value methodology The following methods and assumptions are used to estimate the fair value of our financial instruments: Foreign currency and commodity derivative contracts The fair value is estimated using market-based inputs, obtained from independent pricing services, entered into valuation models. These valuation models require various inputs, including contractual terms, market foreign exchange prices, market commodity prices, interest-rate yield curves, and currency volatilities, as applicable (Level 2 fair value measurement). Short-term borrowings Our short-term borrowings consist of our commercial paper program and the revolving credit facility under our senior credit facility. The revolving credit facility is a variable interest rate bearing note with a fixed margin, adjustable based upon our debt rating (as defined in our senior credit facility). For these short-term borrowings, the carrying value approximates the fair value. Long-term debt The fair value of our fixed interest rate long-term debt is estimated by discounting cash flows using interest rates currently available for debt with similar terms and maturities (Level 2 fair value measurement). As of May 31, 2024, the carrying amount of long-term debt, including the current portion, was $11,089.1 million, compared with an estimated fair value of $10,176.1 million. As of February 29, 2024, the carrying amount of long- term debt, including the current portion, was $11,637.9 million, compared with an estimated fair value of $10,775.8 million. The carrying amounts of certain of our financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value as of May 31, 2024, and February 29, 2024, due to the relatively short maturity of these instruments. Recurring basis measurements The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair Value Measurements Using Quoted Significant Significant Total (in millions) May 31, 2024 Assets: Foreign currency contracts $ — $ 291.7 $ — $ 291.7 Commodity derivative contracts $ — $ 16.9 $ — $ 16.9 Liabilities: Foreign currency contracts $ — $ 6.8 $ — $ 6.8 Commodity derivative contracts $ — $ 23.6 $ — $ 23.6 February 29, 2024 Assets: Foreign currency contracts $ — $ 311.2 $ — $ 311.2 Commodity derivative contracts $ — $ 6.2 $ — $ 6.2 Liabilities: Foreign currency contracts $ — $ 5.4 $ — $ 5.4 Commodity derivative contracts $ — $ 36.0 $ — $ 36.0 Nonrecurring basis measurements The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the periods presented: Fair Value Measurements Using Quoted Significant Significant Total Losses (in millions) For the Three Months Ended May 31, 2023 Equity method investments $ 142.7 $ — $ — $ 123.5 Equity method investments We evaluated the Canopy Equity Method Investment as of May 31, 2023, and determined there was an other-than-temporary impairment. Our conclusion was based on several contributing factors, including: (i) the fair value being less than the carrying value and the uncertainty surrounding Canopy’s stock price recovering in the near-term, (ii) Canopy recorded significant costs in its fourth quarter of fiscal 2023 results designed to align its Canadian cannabis operations and resources in response to continued unfavorable market trends, (iii) the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, and (iv) C anopy’s identification of material misstatements in certain of its previously reported financial results related to sales in its BioSteel Sports Nutrition Inc. reporting unit that were accounted for incorrectly, including the recording of a goodwill impairment during its restated second quarter of fiscal 2023. As a result, the Canopy Equity Method Investment with a carrying value of $266.2 million was written down to its estimated fair value of $142.7 million, resulting in an impairment of $123.5 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the three months ended May 31, 2023. The estimated fair value was determined based on the closing price of the underlying equity security as of May 31, 2023. We no longer apply the equity method to our investment in Canopy following the April 2024 conversion of our Canopy common shares to Exchangeable Shares. See Note 7 for further discussion.

Goodwill

Goodwill	3 Months Ended
Goodwill	May 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL	GOODWILL The changes in the carrying amount of goodwill are as follows: Beer Wine and Spirits Consolidated (in millions) Balance, February 28, 2023 $ 5,188.9 $ 2,736.5 $ 7,925.4 Purchase accounting allocations (1) — 6.5 6.5 Foreign currency translation adjustments 49.3 (0.9) 48.4 Balance, February 29, 2024 5,238.2 2,742.1 7,980.3 Foreign currency translation adjustments 4.4 0.7 5.1 Balance, May 31, 2024 $ 5,242.6 $ 2,742.8 $ 7,985.4 (1) Purchase accounting allocations associated with the June 2023 acquisition of the Domaine Curry wine business. If broader industry and market conditions decline and/or our expectations of future performance as reflected in our current strategic operating plans are not fully realized, a future impairment of Wine and Spirits goodwill is reasonably possible. Subsequent event Sea Smoke acquisition In June 2024, we acquired the Sea Smoke business, including a California-based luxury wine brand, vineyards, and a production facility for $170.0 million, subject to adjustments. This transaction also included the acquisition of a trademark, inventory, and goodwill. The results of operations of Sea Smoke will be reported in the Wine and Spirits segment and will be included in our consolidated results of operations from the date of acquisition.

Intangible Assets

Intangible Assets	3 Months Ended
Intangible Assets	May 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	INTANGIBLE ASSETS The major components of intangible assets are as follows: May 31, 2024 February 29, 2024 Gross Net Gross Net (in millions) Amortizable intangible assets Customer relationships $ 85.4 $ 15.8 $ 85.3 $ 16.2 Other 20.8 0.3 20.8 0.3 Total $ 106.2 16.1 $ 106.1 16.5 Nonamortizable intangible assets Trademarks 2,715.4 2,715.2 Total intangible assets $ 2,731.5 $ 2,731.7 We did not incur costs to renew or extend the term of acquired intangible assets for the three months ended May 31, 2024, and May 31, 2023. Net carrying amount represents the gross carrying value net of accumulated amortization.

Other Assets

Other Assets	3 Months Ended
Other Assets	May 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
OTHER ASSETS	OTHER ASSETS The major components of other assets are as follows: May 31, February 29, (in millions) Operating lease right-of-use asset $ 606.2 $ 615.3 Derivative assets 146.7 154.9 Equity method investments 126.9 170.6 Exchangeable Shares 97.3 — Other investments in debt and equity securities 86.0 73.0 Assets held for sale 26.1 25.7 Other 107.3 100.5 $ 1,196.5 $ 1,140.0 Equity method investments The carrying value of our equity method investments are as follows: May 31, February 29, (in millions) Canopy Equity Method Investment (1) $ — $ 42.5 Other equity method investments 126.9 128.1 $ 126.9 $ 170.6 (1) Following the April 2024 conversion to Exchangeable Shares we no longer apply the equity method. Exchangeable Shares In April 2024, we elected to convert our 17.1 million Canopy common shares into Exchangeable Shares on a one-for-one basis. Additionally, in April 2024, we exchanged C$81.2 million of the principal amount of the C$100.0 million 4.25% promissory note issued to us by Canopy for 9.1 million Exchangeable Shares and forgave all accrued but unpaid interest together with the remaining principal amount of the note. As a result of these transactions, we (i) have 26.3 million Exchangeable Shares and (ii) recognized an $83.3 million net gain in income (loss) from unconsolidated investments within our consolidated results of operations for the three months ended May 31, 2024. The fair value of Exchangeable Shares on the date of the conversion and exchange was estimated using a valuation model based primarily on the following inputs: (i) Canopy’s common share price, (ii) the expected volatility of Canopy’s common shares, and (iii) the probability and timing of U.S. federal legalization of recreational cannabis. As the Exchangeable Shares are an equity security without a readily determinable fair value, we elected to account for the Exchangeable Shares under the measurement alternative method. Future impairments, if any, will also be reported in income (loss) from unconsolidated investments within our consolidated results. Other investments in debt and equity securities We have multiple investments through our corporate venture capital function in debt and equity securities. Subsequent event Mexicali Brewery In July 2024, we closed on the sale of the remaining assets classified as held for sale at the canceled Mexicali Brewery. These net assets had met held for sale criteria as of May 31, 2024, and February 29, 2024.

Borrowings

Borrowings	3 Months Ended
Borrowings	May 31, 2024
Debt Disclosure [Abstract]
BORROWINGS	BORROWINGS Borrowings consist of the following: May 31, 2024 February 29, Current Long-term Total Total (in millions) Short-term borrowings Commercial paper $ 793.2 $ 241.4 $ 793.2 $ 241.4 Long-term debt Senior notes $ 399.7 $ 10,673.7 $ 11,073.4 $ 11,620.1 Other 6.5 9.2 15.7 17.8 $ 406.2 $ 10,682.9 $ 11,089.1 $ 11,637.9 Bank facilities The Company, CB International, the Administrative Agent, and certain other lenders are parties to the 2022 Credit Agreement. The October 2022 Credit Agreement Amendment revised certain defined terms and covenants in the 2022 Credit Agreement and became effective in April 2024 following (i) the amendment by Canopy of its Articles of Incorporation, (ii) the conversion of our Canopy common shares into Exchangeable Shares, and (iii) the resignation of our nominees from the board of directors of Canopy. Information with respect to borrowings under the 2022 Credit Agreement is as follows: Outstanding Interest SOFR Outstanding Remaining borrowing capacity (1) (in millions) May 31, 2024 Revolving credit facility (2) (3) $ — — % — % $ 11.4 $ 1,443.1 February 29, 2024 Revolving credit facility (2) (3) $ — — % — % $ 11.5 $ 1,997.0 (1) Net of outstanding revolving credit facility borrowings and outstanding letters of credit under the 2022 Credit Agreement and outstanding borrowings under our commercial paper program of $795.5 million and $241.5 million (excluding unamortized discount) as of May 31, 2024 and February 29, 2024, respectively (see “Commercial paper program” below). (2) Contractual interest rate varies based on our debt rating (as defined in the agreement) and is a function of SOFR plus a margin and a credit spread adjustment, or the base rate plus a margin, or, in certain circumstances where SOFR cannot be adequately ascertained or available, an alternative benchmark rate plus a margin. (3) We and/or CB International are the borrower under the $2,250.0 million revolving credit facility with a maturity date of April 14, 2027. Includes a sub-facility for letters of credit of up to $200.0 million. We and our subsidiaries are subject to covenants that are contained in the 2022 Credit Agreement, including those restricting the incurrence of additional subsidiary indebtedness, additional liens, mergers and consolidations, transactions with affiliates, and sale and leaseback transactions, in each case subject to numerous conditions, exceptions, and thresholds. The financial covenants are limited to a minimum interest coverage ratio and a maximum net leverage ratio. Commercial paper program We have a commercial paper program which provides for the issuance of up to an aggregate principal amount of $2.25 billion of commercial paper. Our commercial paper program is backed by unused commitments under our revolving credit facility under our 2022 Credit Agreement. Accordingly, outstanding borrowings under our commercial paper program reduce the amount available under our revolving credit facility. Information with respect to our outstanding commercial paper borrowings is as follows: May 31, February 29, (in millions) Outstanding borrowings (1) $ 793.2 $ 241.4 Weighted average annual interest rate 5.7 % 5.7 % Weighted average remaining term 20 days 4 days (1) Outstanding commercial paper borrowings are net of unamortized discount. Debt payments As of May 31, 2024, the required principal repayments under long-term debt obligations (excluding unamortized debt issuance costs and unamortized discounts of $53.8 million and $22.8 million, respectively) for the remaining nine months of Fiscal 2025 and for each of the five succeeding fiscal years and thereafter are as follows: (in millions) Fiscal 2025 $ 405.3 Fiscal 2026 1,404.9 Fiscal 2027 603.8 Fiscal 2028 1,801.5 Fiscal 2029 900.1 Fiscal 2030 800.0 Thereafter 5,250.1 $ 11,165.7

Income Taxes

Income Taxes	3 Months Ended
Income Taxes	May 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Our effective tax rate for the three months ended May 31, 2024, and May 31, 2023, was 3.0% and 39.6%, respectively. For the three months ended May 31, 2024, our effective tax rate was lower than the federal statutory rate of 21% primarily due to (i) a net income tax benefit recognized as a result of the resolution of various tax examinations and assessments related to prior periods, (ii) the benefit of lower effective tax rates applicable to our foreign businesses, and (iii) a decrease in the valuation allowance related to our investment in Canopy. For the three months ended May 31, 2023, our effective tax rate was higher than the federal statutory rate of 21% primarily due to an increase in the valuation allowance related to our investment in Canopy, partially offset by (i) a net income tax benefit recognized as a result of a change in tax entity classification and (ii) the benefit of lower effective tax rates applicable to our foreign businesses. The Organization for Economic Cooperation and Development introduced a framework under Pillar Two which includes a global minimum tax rate of 15%. Many jurisdictions in which we do business have started to enact laws implementing Pillar Two. We are monitoring these developments and currently do not believe these rules will have a material impact on our financial condition and/or consolidated results.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
Stockholders' Equity	May 31, 2024
Equity [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Common stock The number of shares of common stock issued and treasury stock, and associated share activity, are as follows: Class A Stock Class 1 Stock Class A Stock in Treasury Balance at February 29, 2024 212,698,298 23,661 29,809,881 Share repurchases — — 775,334 Exercise of stock options — 1,880 (149,324) Vesting of restricted stock units (1) — — (85,650) Vesting of performance share units (1) — — (8,757) Balance at May 31, 2024 212,698,298 25,541 30,341,484 Class A Stock Class 1 Stock Class A Stock in Treasury Balance at February 28, 2023 212,697,428 22,705 29,498,426 Share repurchases — — 153,937 Conversion of shares 80 (80) — Exercise of stock options — 800 (129,595) Vesting of restricted stock units (1) — — (71,189) Vesting of performance share units (1) — — (13,113) Balance at May 31, 2023 212,697,508 23,425 29,438,466 (1) Net of the following shares withheld to satisfy tax withholding requirements: For the Three 2024 Restricted Stock Units 48,501 Performance Share Units 5,728 2023 Restricted Stock Units 39,839 Performance Share Units 8,735 Stock repurchases In each of January 2021 and November 2023, our Board of Directors authorized the repurchase of up to $2.0 billion of our publicly traded common stock. The Board of Directors did not specify a date upon which these authorizations would expire. Shares repurchased under these authorizations become treasury shares. For the three months ended May 31, 2024, we repurchased 775,334 shares of Class A Stock pursuant to the 2021 Authorization through open market transactions at an aggregate cost of $200.0 million. Beginning May 31, 2024, we repurchased 187,843 shares of Class A Stock pursuant to the 2021 Authorization at an aggregate cost of $47.0 million through open market transactions made pursuant to a Rule 10b5-1 trading plan. As of July 3, 2024, total shares repurchased under our board authorizations are as follows: Class A Stock Repurchase Dollar Value Number of (in millions, except share data) 2021 Authorization (1) $ 2,000.0 $ 1,633.3 6,838,453 2023 Authorization (1) $ 2,000.0 $ — — (1) As of July 3, 2024, $2,366.7 million remains available for future share repurchases, excluding the impact of Federal excise tax owed pursuant to the IRA.

Net Income (Loss) Per Common Sh

Net Income (Loss) Per Common Share Attributable to CBI	3 Months Ended
Net Income (Loss) Per Common Share Attributable to CBI	May 31, 2024
Earnings Per Share [Abstract]
NET INCOME (LOSS) PER COMMON SHARE ATTRIBUTABLE TO CBI	NET INCOME (LOSS) PER COMMON SHARE ATTRIBUTABLE TO CBI For the three months ended May 31, 2024, and May 31, 2023, net income (loss) per common share – basic for Class A Stock has been computed based on the weighted average shares of common stock outstanding during the period. Net income (loss) per common share – diluted for Class A Stock reflects the weighted average shares of common stock plus the effect of dilutive securities outstanding during the period using the treasury stock method. The effect of dilutive securities includes the impact of outstanding stock-based awards. The dilutive computation does not assume conversion, exercise, or contingent issuance of securities that would have an anti-dilutive effect on the net income (loss) per common share attributable to CBI. The computation of basic and diluted net income (loss) per common share for Class A Stock are as follows: For the Three Months 2024 2023 (in millions, except per share data) Net income (loss) attributable to CBI $ 877.0 $ 135.9 Weighted average common shares outstanding – basic 182.766 183.270 Stock-based awards, primarily stock options 0.695 0.593 Weighted average common shares outstanding – diluted 183.461 183.863 Net income (loss) per common share attributable to CBI – basic $ 4.80 $ 0.74 Net income (loss) per common share attributable to CBI – diluted $ 4.78 $ 0.74

Comprehensive Income (Loss) Att

Comprehensive Income (Loss) Attributable to CBI	3 Months Ended
Comprehensive Income (Loss) Attributable to CBI	May 31, 2024
Equity [Abstract]
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI	COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI Comprehensive income (loss) consists of net income (loss), foreign currency translation adjustments, unrealized net gain (loss) on derivative instruments, pension/postretirement adjustments, and our share of OCI of equity method investments. The reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI is as follows: Before Tax Tax (Expense) Net of Tax (in millions) For the Three Months Ended May 31, 2024 Net income (loss) attributable to CBI $ 877.0 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 13.5 $ — 13.5 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 13.5 — 13.5 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 28.2 (3.3) 24.9 Amounts reclassified (42.1) 5.0 (37.1) Net gain (loss) recognized in other comprehensive income (loss) (13.9) 1.7 (12.2) Share of OCI of equity method investments Net gain (loss) — — — Amounts reclassified (10.3) — (10.3) Net gain (loss) recognized in other comprehensive income (loss) (10.3) — (10.3) Other comprehensive income (loss) attributable to CBI $ (10.7) $ 1.7 (9.0) Comprehensive income (loss) attributable to CBI $ 868.0 Before Tax Tax (Expense) Net of Tax (in millions) For the Three Months Ended May 31, 2023 Net income (loss) attributable to CBI $ 135.9 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 163.4 $ — 163.4 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 163.4 — 163.4 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 86.4 (10.4) 76.0 Amounts reclassified (27.8) 3.2 (24.6) Net gain (loss) recognized in other comprehensive income (loss) 58.6 (7.2) 51.4 Pension/postretirement adjustments: Net actuarial gain (loss) (0.3) 0.1 (0.2) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.3) 0.1 (0.2) Share of OCI of equity method investments Net gain (loss) (0.3) 0.1 (0.2) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.3) 0.1 (0.2) Other comprehensive income (loss) attributable to CBI $ 221.4 $ (7.0) 214.4 Comprehensive income (loss) attributable to CBI $ 350.3 Accumulated other comprehensive income (loss), net of income tax effect, includes the following components: Foreign Unrealized Net Pension/ Share of OCI Accumulated (in millions) Balance, February 29, 2024 $ 102.9 $ 266.2 $ (2.6) $ 10.3 $ 376.8 Other comprehensive income (loss): Other comprehensive income (loss) before reclassification adjustments 13.5 24.9 — — 38.4 Amounts reclassified from accumulated other comprehensive income (loss) — (37.1) — (10.3) (47.4) Other comprehensive income (loss) 13.5 (12.2) — (10.3) (9.0) Balance, May 31, 2024 $ 116.4 $ 254.0 $ (2.6) $ — $ 367.8

Business Segment Information

Business Segment Information	3 Months Ended
Business Segment Information	May 31, 2024
Segment Reporting [Abstract]
BUSINESS SEGMENT INFORMATION	BUSINESS SEGMENT INFORMATION O ur internal management financial reporting consists of two business divisions: (i) Beer and (ii) Wine and Spirits and we report our operating results in three segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other. In the Beer segment, our portfolio consists of high-end imported beer brands and ABAs. We have an exclusive perpetual brand license to produce our Mexican beer portfolio and to import, market, and sell such portfolio in the U.S. In the Wine and Spirits segment, we sell a portfolio that includes higher-end wine brands complemented by certain higher-end spirits brands. Amounts included in the Corporate Operations and Other segment consist of costs of corporate development, corporate finance, corporate strategy, executive management, growth, human resources, internal audit, investor relations, IT, legal, and public relations, as well as our Canopy investment and investments made through our corporate venture capital function . All costs included in the Corporate Operations and Other segment are general costs that are applicable to the consolidated group and are, therefore, not allocated to the other reportable segments. All costs reported within the Corporate Operations and Other segment are not included in our CODM’s evaluation of the operating income (loss) performance of the other reportable segments. The business segments reflect how our operations are managed, how resources are allocated, how operating performance is evaluated by senior management, and the structure of our internal financial reporting. Long-lived tangible assets and total asset information by segment is not provided to, or reviewed by, our CODM as it is not used to make strategic decisions, allocate resources, or assess performance. In addition, management excludes Comparable Adjustments from its evaluation of the results of each operating segment as these Comparable Adjustments are not reflective of core operations of the segments. Segment operating performance and the incentive compensation of segment management are evaluated based on core segment operating income (loss) which does not include the impact of these Comparable Adjustments. We evaluate segment operating performance based on operating income (loss) of the respective business units. Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows: For the Three Months 2024 2023 (in millions) Cost of product sold Net gain (loss) on undesignated commodity derivative contracts $ 14.6 $ (34.7) Settlements of undesignated commodity derivative contracts 8.5 0.6 Flow through of inventory step-up (1.1) (0.7) Comparable Adjustments, Cost of product sold 22.0 (34.8) Selling, general, and administrative expenses Transition services agreements activity (2.8) (5.7) Restructuring and other strategic business development costs (1.8) (14.9) Transaction, integration, and other acquisition-related costs (0.2) (0.3) Other gains (losses) (1) 0.4 (6.8) Comparable Adjustments, Selling, general, and administrative expenses (4.4) (27.7) Comparable Adjustments, Operating income (loss) $ 17.6 $ (62.5) (1) Primarily includes the following: For the Three Months 2024 2023 (in millions) Gain (loss) on sale of business $ — $ (7.0) The accounting policies of the segments are the same as those described for the Company in Note 1 of our consolidated financial statements included in our 2024 Annual Report. Segment information is as follows: For the Three Months 2024 2023 (in millions) Beer Net sales $ 2,272.8 $ 2,098.6 Segment operating income (loss) $ 923.0 $ 797.8 Capital expenditures $ 314.4 $ 205.6 Depreciation and amortization $ 86.4 $ 78.8 Wine and Spirits Net sales: Wine $ 329.3 $ 361.0 Spirits 59.7 55.3 Net sales $ 389.0 $ 416.3 Segment operating income (loss) $ 59.7 $ 79.3 Income (loss) from unconsolidated investments $ 0.4 $ 2.3 Equity method investments $ 101.2 $ 96.8 Capital expenditures $ 49.6 $ 38.6 Depreciation and amortization $ 21.3 $ 22.5 Corporate Operations and Other Segment operating income (loss) $ (58.7) $ (49.9) Income (loss) from unconsolidated investments $ (1.7) $ (33.3) Equity method investments $ 25.7 $ 194.5 Capital expenditures $ 11.3 $ 32.8 Depreciation and amortization $ 4.2 $ 4.4 Comparable Adjustments Operating income (loss) $ 17.6 $ (62.5) Income (loss) from unconsolidated investments $ 83.3 $ (384.4) Consolidated Net sales $ 2,661.8 $ 2,514.9 Operating income (loss) $ 941.6 $ 764.7 Income (loss) from unconsolidated investments (1) $ 82.0 $ (415.4) Equity method investments $ 126.9 $ 291.3 Capital expenditures $ 375.3 $ 277.0 Depreciation and amortization $ 111.9 $ 105.7 (1) Income (loss) from unconsolidated investments consists of: For the Three Months 2024 2023 (in millions) Net gain on conversion and exchange to Exchangeable Shares (i) $ 83.3 $ — Equity in earnings (losses) from other equity method investees and related activities (1.3) (0.3) Equity in earnings (losses) from Canopy and related activities — (219.8) Impairment of equity method investments — (123.5) Unrealized net gain (loss) on securities measured at fair value (i) — (71.8) $ 82.0 $ (415.4) (i) Effective as of May 31, 2023, we determined that the 2023 Canopy Promissory Note did not have future economic value given the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, prior to the maturity of the note. Accordingly, the fair value of the remaining balance for this instrument was determined to be zero. In April 2024, we exchanged the 2023 Canopy Promissory Note for Exchangeable Shares.

Accounting Guidance Not Yet Ado

Accounting Guidance Not Yet Adopted	3 Months Ended
Accounting Guidance Not Yet Adopted	May 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounting Guidance Not Yet Adopted	ACCOUNTING GUIDANCE NOT YET ADOPTED Segment reporting In November 2023, the FASB issued a standard requiring disclosures, on an annual and interim basis, of significant segment expenses and other segment items that are regularly provided to the CODM as well as the title and position of the CODM. We are required to adopt these disclosures for our annual period ending February 28, 2025, and interim periods beginning March 1, 2025, with early adoption permitted. The amendments in this standard will be applied retrospectively to all prior periods presented in the financial statements. We expect this standard to impact our disclosures with no material impacts to our results of operations, cash flows, or financial condition. Income taxes In December 2023, the FASB issued a standard aimed at improving tax disclosure requirements, primarily through enhanced disclosures related to the income tax rate reconciliation and income taxes paid. We are required to adopt these disclosures for our annual period ending February 28, 2026, with early adoption permitted and this standard may be applied retrospectively. We expect this standard to impact our disclosures with no material impacts to our results of operations, cash flows, or financial condition. Climate In March 2024, the SEC adopted final rules to require disclosures about certain climate-related information in registration statements and annual reports. In April 2024, the SEC issued an order to stay the rules pending the completion of judicial review of multiple petitions challenging the rules. The rules will require disclosure of, among other things, material climate-related risks, how the board of directors and management oversee and manage such risks, and the actual and potential material impacts of such risks on us. The rules also require disclosure about material climate-related targets and goals, Scope 1 and Scope 2 GHG emissions, and the financial impacts of severe weather events and other natural conditions. The SEC has indicated that it will publish a new effective date for the rules, if ultimately implemented, at the conclusion of the stay. These rules will be applied prospectively. We are currently assessing the impact of these rules on our SEC filings.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	May 31, 2024	May 31, 2023
Pay vs Performance Disclosure
Net income (loss) attributable to CBI	$ 877	$ 135.9

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	May 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
Basis of Presentation (Policies)	May 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	We have prepared the Financial Statements, without audit, pursuant to the rules and regulations of the SEC applicable to quarterly reporting on Form 10-Q and reflect, in our opinion, all adjustments necessary to present fairly our financial information. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements, prepared in accordance with generally accepted accounting principles, have been condensed or omitted as permitted by such rules and regulations. These Financial Statements should be read in conjunction with the consolidated financial statements and related notes included in the 2024 Annual Report. Results of operations for interim periods are not necessarily indicative of annual results.

Inventories (Tables)

Inventories (Tables)	3 Months Ended
Inventories (Tables)	May 31, 2024
Inventory Disclosure [Abstract]
Schedule of Components of Inventories	Elements of cost include materials, labor, and overhead and consist of the following: May 31, February 29, (in millions) Raw materials and supplies $ 244.1 $ 254.1 In-process inventories 1,109.5 1,096.0 Finished case goods 773.4 728.2 $ 2,127.0 $ 2,078.3

Derivative Instruments (Tables)

Derivative Instruments (Tables)	3 Months Ended
Derivative Instruments (Tables)	May 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Aggregate notional value of outstanding derivative instruments	The aggregate notional value of outstanding derivative instruments is as follows: May 31, February 29, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts $ 2,083.1 $ 2,045.6 Derivative instruments not designated as hedging instruments Foreign currency contracts $ 829.5 $ 735.9 Commodity derivative contracts $ 351.5 $ 397.5
Fair value and location of derivative instruments on our balance sheets	The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 4): Assets Liabilities May 31, February 29, May 31, February 29, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 148.0 $ 154.1 Other accrued expenses and liabilities $ 2.5 $ 3.5 Other assets $ 141.0 $ 153.5 Deferred income taxes and other liabilities $ 0.5 $ 0.2 Derivative instruments not designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 2.7 $ 3.6 Other accrued expenses and liabilities $ 3.8 $ 1.7 Commodity derivative contracts: Prepaid expenses and other $ 11.2 $ 4.8 Other accrued expenses and liabilities $ 19.1 $ 27.9 Other assets $ 5.7 $ 1.4 Deferred income taxes and other liabilities $ 4.5 $ 8.1
Effect of derivative instruments on our results of operations and OCI	The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows: Derivative Instruments in Net Location of Net Gain (Loss) Net (in millions) For the Three Months Ended May 31, 2024 Foreign currency contracts $ 26.1 Sales $ 0.1 Cost of product sold 39.1 $ 26.1 $ 39.2 For the Three Months Ended May 31, 2023 Foreign currency contracts $ 79.3 Sales $ — Cost of product sold 26.4 Pre-issuance hedge contracts 0.6 Interest expense, net (0.2) $ 79.9 $ 26.2 The effect of our undesignated derivative instruments on our results of operations is as follows: Derivative Instruments Not Location of Net Gain (Loss) Net (in millions) For the Three Months Ended May 31, 2024 Commodity derivative contracts Cost of product sold $ 14.6 Foreign currency contracts Selling, general, and administrative expenses 4.0 $ 18.6 For the Three Months Ended May 31, 2023 Commodity derivative contracts Cost of product sold $ (34.7) Foreign currency contracts Selling, general, and administrative expenses 12.7 $ (22.0)

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
Fair Value of Financial Instruments (Tables)	May 31, 2024
Fair Value Disclosures [Abstract]
Financial assets and liabilities measured at estimated fair value on a recurring basis	The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair Value Measurements Using Quoted Significant Significant Total (in millions) May 31, 2024 Assets: Foreign currency contracts $ — $ 291.7 $ — $ 291.7 Commodity derivative contracts $ — $ 16.9 $ — $ 16.9 Liabilities: Foreign currency contracts $ — $ 6.8 $ — $ 6.8 Commodity derivative contracts $ — $ 23.6 $ — $ 23.6 February 29, 2024 Assets: Foreign currency contracts $ — $ 311.2 $ — $ 311.2 Commodity derivative contracts $ — $ 6.2 $ — $ 6.2 Liabilities: Foreign currency contracts $ — $ 5.4 $ — $ 5.4 Commodity derivative contracts $ — $ 36.0 $ — $ 36.0
Assets and liabilities measured at estimated fair value on a nonrecurring basis	The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the periods presented: Fair Value Measurements Using Quoted Significant Significant Total Losses (in millions) For the Three Months Ended May 31, 2023 Equity method investments $ 142.7 $ — $ — $ 123.5

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
Goodwill (Tables)	May 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in the carrying amount of goodwill	The changes in the carrying amount of goodwill are as follows: Beer Wine and Spirits Consolidated (in millions) Balance, February 28, 2023 $ 5,188.9 $ 2,736.5 $ 7,925.4 Purchase accounting allocations (1) — 6.5 6.5 Foreign currency translation adjustments 49.3 (0.9) 48.4 Balance, February 29, 2024 5,238.2 2,742.1 7,980.3 Foreign currency translation adjustments 4.4 0.7 5.1 Balance, May 31, 2024 $ 5,242.6 $ 2,742.8 $ 7,985.4 (1) Purchase accounting allocations associated with the June 2023 acquisition of the Domaine Curry wine business.

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
Intangible Assets (Tables)	May 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Major components of intangible assets, Amortizable intangible assets	The major components of intangible assets are as follows: May 31, 2024 February 29, 2024 Gross Net Gross Net (in millions) Amortizable intangible assets Customer relationships $ 85.4 $ 15.8 $ 85.3 $ 16.2 Other 20.8 0.3 20.8 0.3 Total $ 106.2 16.1 $ 106.1 16.5 Nonamortizable intangible assets Trademarks 2,715.4 2,715.2 Total intangible assets $ 2,731.5 $ 2,731.7
Major components of intangible assets, Nonamortizable intangible assets	The major components of intangible assets are as follows: May 31, 2024 February 29, 2024 Gross Net Gross Net (in millions) Amortizable intangible assets Customer relationships $ 85.4 $ 15.8 $ 85.3 $ 16.2 Other 20.8 0.3 20.8 0.3 Total $ 106.2 16.1 $ 106.1 16.5 Nonamortizable intangible assets Trademarks 2,715.4 2,715.2 Total intangible assets $ 2,731.5 $ 2,731.7

Other Assets (Tables)

Other Assets (Tables)	3 Months Ended
Other Assets (Tables)	May 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Components of other assets	The major components of other assets are as follows: May 31, February 29, (in millions) Operating lease right-of-use asset $ 606.2 $ 615.3 Derivative assets 146.7 154.9 Equity method investments 126.9 170.6 Exchangeable Shares 97.3 — Other investments in debt and equity securities 86.0 73.0 Assets held for sale 26.1 25.7 Other 107.3 100.5 $ 1,196.5 $ 1,140.0
Equity method investments	The carrying value of our equity method investments are as follows: May 31, February 29, (in millions) Canopy Equity Method Investment (1) $ — $ 42.5 Other equity method investments 126.9 128.1 $ 126.9 $ 170.6 (1) Following the April 2024 conversion to Exchangeable Shares we no longer apply the equity method.

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
Borrowings (Tables)	May 31, 2024
Debt Disclosure [Abstract]
Borrowings	Borrowings consist of the following: May 31, 2024 February 29, Current Long-term Total Total (in millions) Short-term borrowings Commercial paper $ 793.2 $ 241.4 $ 793.2 $ 241.4 Long-term debt Senior notes $ 399.7 $ 10,673.7 $ 11,073.4 $ 11,620.1 Other 6.5 9.2 15.7 17.8 $ 406.2 $ 10,682.9 $ 11,089.1 $ 11,637.9 Information with respect to borrowings under the 2022 Credit Agreement is as follows: Outstanding Interest SOFR Outstanding Remaining borrowing capacity (1) (in millions) May 31, 2024 Revolving credit facility (2) (3) $ — — % — % $ 11.4 $ 1,443.1 February 29, 2024 Revolving credit facility (2) (3) $ — — % — % $ 11.5 $ 1,997.0 (1) Net of outstanding revolving credit facility borrowings and outstanding letters of credit under the 2022 Credit Agreement and outstanding borrowings under our commercial paper program of $795.5 million and $241.5 million (excluding unamortized discount) as of May 31, 2024 and February 29, 2024, respectively (see “Commercial paper program” below). (2) Contractual interest rate varies based on our debt rating (as defined in the agreement) and is a function of SOFR plus a margin and a credit spread adjustment, or the base rate plus a margin, or, in certain circumstances where SOFR cannot be adequately ascertained or available, an alternative benchmark rate plus a margin. (3) We and/or CB International are the borrower under the $2,250.0 million revolving credit facility with a maturity date of April 14, 2027. Includes a sub-facility for letters of credit of up to $200.0 million. May 31, February 29, (in millions) Outstanding borrowings (1) $ 793.2 $ 241.4 Weighted average annual interest rate 5.7 % 5.7 % Weighted average remaining term 20 days 4 days (1) Outstanding commercial paper borrowings are net of unamortized discount.
Schedule of maturities of long-term debt	As of May 31, 2024, the required principal repayments under long-term debt obligations (excluding unamortized debt issuance costs and unamortized discounts of $53.8 million and $22.8 million, respectively) for the remaining nine months of Fiscal 2025 and for each of the five succeeding fiscal years and thereafter are as follows: (in millions) Fiscal 2025 $ 405.3 Fiscal 2026 1,404.9 Fiscal 2027 603.8 Fiscal 2028 1,801.5 Fiscal 2029 900.1 Fiscal 2030 800.0 Thereafter 5,250.1 $ 11,165.7

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
Stockholders' Equity (Tables)	May 31, 2024
Equity [Abstract]
Number of shares of common stock issued and treasury stock, and associated share activity	The number of shares of common stock issued and treasury stock, and associated share activity, are as follows: Class A Stock Class 1 Stock Class A Stock in Treasury Balance at February 29, 2024 212,698,298 23,661 29,809,881 Share repurchases — — 775,334 Exercise of stock options — 1,880 (149,324) Vesting of restricted stock units (1) — — (85,650) Vesting of performance share units (1) — — (8,757) Balance at May 31, 2024 212,698,298 25,541 30,341,484 Class A Stock Class 1 Stock Class A Stock in Treasury Balance at February 28, 2023 212,697,428 22,705 29,498,426 Share repurchases — — 153,937 Conversion of shares 80 (80) — Exercise of stock options — 800 (129,595) Vesting of restricted stock units (1) — — (71,189) Vesting of performance share units (1) — — (13,113) Balance at May 31, 2023 212,697,508 23,425 29,438,466 (1) Net of the following shares withheld to satisfy tax withholding requirements: For the Three 2024 Restricted Stock Units 48,501 Performance Share Units 5,728 2023 Restricted Stock Units 39,839 Performance Share Units 8,735
Summary of share repurchase activity	As of July 3, 2024, total shares repurchased under our board authorizations are as follows: Class A Stock Repurchase Dollar Value Number of (in millions, except share data) 2021 Authorization (1) $ 2,000.0 $ 1,633.3 6,838,453 2023 Authorization (1) $ 2,000.0 $ — — (1) As of July 3, 2024, $2,366.7 million remains available for future share repurchases, excluding the impact of Federal excise tax owed pursuant to the IRA.

Net Income (Loss) Per Common _2

Net Income (Loss) Per Common Share Attributable to CBI (Tables)	3 Months Ended
	May 31, 2024
Earnings Per Share [Abstract]
Basic and diluted net income (loss) per common share attributable to CBI	The computation of basic and diluted net income (loss) per common share for Class A Stock are as follows: For the Three Months 2024 2023 (in millions, except per share data) Net income (loss) attributable to CBI $ 877.0 $ 135.9 Weighted average common shares outstanding – basic 182.766 183.270 Stock-based awards, primarily stock options 0.695 0.593 Weighted average common shares outstanding – diluted 183.461 183.863 Net income (loss) per common share attributable to CBI – basic $ 4.80 $ 0.74 Net income (loss) per common share attributable to CBI – diluted $ 4.78 $ 0.74

Comprehensive Income (Loss) A_2

Comprehensive Income (Loss) Attributable to CBI (Tables)	3 Months Ended
Comprehensive Income (Loss) Attributable to CBI (Tables)	May 31, 2024
Equity [Abstract]
Reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI	The reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI is as follows: Before Tax Tax (Expense) Net of Tax (in millions) For the Three Months Ended May 31, 2024 Net income (loss) attributable to CBI $ 877.0 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 13.5 $ — 13.5 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 13.5 — 13.5 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 28.2 (3.3) 24.9 Amounts reclassified (42.1) 5.0 (37.1) Net gain (loss) recognized in other comprehensive income (loss) (13.9) 1.7 (12.2) Share of OCI of equity method investments Net gain (loss) — — — Amounts reclassified (10.3) — (10.3) Net gain (loss) recognized in other comprehensive income (loss) (10.3) — (10.3) Other comprehensive income (loss) attributable to CBI $ (10.7) $ 1.7 (9.0) Comprehensive income (loss) attributable to CBI $ 868.0 Before Tax Tax (Expense) Net of Tax (in millions) For the Three Months Ended May 31, 2023 Net income (loss) attributable to CBI $ 135.9 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 163.4 $ — 163.4 Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) 163.4 — 163.4 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 86.4 (10.4) 76.0 Amounts reclassified (27.8) 3.2 (24.6) Net gain (loss) recognized in other comprehensive income (loss) 58.6 (7.2) 51.4 Pension/postretirement adjustments: Net actuarial gain (loss) (0.3) 0.1 (0.2) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.3) 0.1 (0.2) Share of OCI of equity method investments Net gain (loss) (0.3) 0.1 (0.2) Amounts reclassified — — — Net gain (loss) recognized in other comprehensive income (loss) (0.3) 0.1 (0.2) Other comprehensive income (loss) attributable to CBI $ 221.4 $ (7.0) 214.4 Comprehensive income (loss) attributable to CBI $ 350.3
Accumulated other comprehensive income (loss), net of income tax effect	Accumulated other comprehensive income (loss), net of income tax effect, includes the following components: Foreign Unrealized Net Pension/ Share of OCI Accumulated (in millions) Balance, February 29, 2024 $ 102.9 $ 266.2 $ (2.6) $ 10.3 $ 376.8 Other comprehensive income (loss): Other comprehensive income (loss) before reclassification adjustments 13.5 24.9 — — 38.4 Amounts reclassified from accumulated other comprehensive income (loss) — (37.1) — (10.3) (47.4) Other comprehensive income (loss) 13.5 (12.2) — (10.3) (9.0) Balance, May 31, 2024 $ 116.4 $ 254.0 $ (2.6) $ — $ 367.8

Business Segment Information (T

Business Segment Information (Tables)	3 Months Ended
Business Segment Information (Tables)	May 31, 2024
Segment Reporting [Abstract]
Comparable adjustments	Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows: For the Three Months 2024 2023 (in millions) Cost of product sold Net gain (loss) on undesignated commodity derivative contracts $ 14.6 $ (34.7) Settlements of undesignated commodity derivative contracts 8.5 0.6 Flow through of inventory step-up (1.1) (0.7) Comparable Adjustments, Cost of product sold 22.0 (34.8) Selling, general, and administrative expenses Transition services agreements activity (2.8) (5.7) Restructuring and other strategic business development costs (1.8) (14.9) Transaction, integration, and other acquisition-related costs (0.2) (0.3) Other gains (losses) (1) 0.4 (6.8) Comparable Adjustments, Selling, general, and administrative expenses (4.4) (27.7) Comparable Adjustments, Operating income (loss) $ 17.6 $ (62.5) (1) Primarily includes the following: For the Three Months 2024 2023 (in millions) Gain (loss) on sale of business $ — $ (7.0)
Segment information	Segment information is as follows: For the Three Months 2024 2023 (in millions) Beer Net sales $ 2,272.8 $ 2,098.6 Segment operating income (loss) $ 923.0 $ 797.8 Capital expenditures $ 314.4 $ 205.6 Depreciation and amortization $ 86.4 $ 78.8 Wine and Spirits Net sales: Wine $ 329.3 $ 361.0 Spirits 59.7 55.3 Net sales $ 389.0 $ 416.3 Segment operating income (loss) $ 59.7 $ 79.3 Income (loss) from unconsolidated investments $ 0.4 $ 2.3 Equity method investments $ 101.2 $ 96.8 Capital expenditures $ 49.6 $ 38.6 Depreciation and amortization $ 21.3 $ 22.5 Corporate Operations and Other Segment operating income (loss) $ (58.7) $ (49.9) Income (loss) from unconsolidated investments $ (1.7) $ (33.3) Equity method investments $ 25.7 $ 194.5 Capital expenditures $ 11.3 $ 32.8 Depreciation and amortization $ 4.2 $ 4.4 Comparable Adjustments Operating income (loss) $ 17.6 $ (62.5) Income (loss) from unconsolidated investments $ 83.3 $ (384.4) Consolidated Net sales $ 2,661.8 $ 2,514.9 Operating income (loss) $ 941.6 $ 764.7 Income (loss) from unconsolidated investments (1) $ 82.0 $ (415.4) Equity method investments $ 126.9 $ 291.3 Capital expenditures $ 375.3 $ 277.0 Depreciation and amortization $ 111.9 $ 105.7 (1) Income (loss) from unconsolidated investments consists of: For the Three Months 2024 2023 (in millions) Net gain on conversion and exchange to Exchangeable Shares (i) $ 83.3 $ — Equity in earnings (losses) from other equity method investees and related activities (1.3) (0.3) Equity in earnings (losses) from Canopy and related activities — (219.8) Impairment of equity method investments — (123.5) Unrealized net gain (loss) on securities measured at fair value (i) — (71.8) $ 82.0 $ (415.4) (i) Effective as of May 31, 2023, we determined that the 2023 Canopy Promissory Note did not have future economic value given the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, prior to the maturity of the note. Accordingly, the fair value of the remaining balance for this instrument was determined to be zero. In April 2024, we exchanged the 2023 Canopy Promissory Note for Exchangeable Shares.

Inventories - Schedule of Costs

Inventories - Schedule of Costs of Inventory (Details) - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 244.1	$ 254.1
In-process inventories	1,109.5	1,096
Finished case goods	773.4	728.2
Inventories, Total	$ 2,127	$ 2,078.3

Derivative Instruments - Aggreg

Derivative Instruments - Aggregate Notional Value of Outstanding Derivative Instruments (Details) - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024
Derivative instruments designated as hedging instruments \| Foreign currency contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	$ 2,083.1	$ 2,045.6
Derivative instruments not designated as hedging instruments \| Foreign currency contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	829.5	735.9
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	$ 351.5	$ 397.5

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) $ in Millions	3 Months Ended
Derivative Instruments - Narrative (Details) $ in Millions	May 31, 2024 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair value of derivative instruments in a net liability position due to counterparties	$ 2.2
Amount of net gains (losses), net of income tax effect, to be reclassified from AOCI to our results of operations within the next 12 months	$ 128.3

Derivative Instruments - Estima

Derivative Instruments - Estimated Fair Value and Location of Derivative Instruments (Details) - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024
Derivative instruments designated as hedging instruments \| Foreign currency contracts \| Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	$ 148	$ 154.1
Derivative instruments designated as hedging instruments \| Foreign currency contracts \| Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	2.5	3.5
Derivative instruments designated as hedging instruments \| Foreign currency contracts \| Other assets
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	141	153.5
Derivative instruments designated as hedging instruments \| Foreign currency contracts \| Deferred income taxes and other liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	0.5	0.2
Derivative instruments not designated as hedging instruments \| Foreign currency contracts \| Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	2.7	3.6
Derivative instruments not designated as hedging instruments \| Foreign currency contracts \| Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	3.8	1.7
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts \| Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Assets	11.2	4.8
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts \| Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Liabilities	19.1	27.9
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts \| Other assets
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Assets	5.7	1.4
Derivative instruments not designated as hedging instruments \| Commodity derivative contracts \| Deferred income taxes and other liabilities
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Liabilities	$ 4.5	$ 8.1

Derivative Instruments - Effect

Derivative Instruments - Effects of Designated and Undesignated Hedging Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2024	May 31, 2023
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	$ 18.6	$ (22)
Foreign currency contracts \| Selling, general, and administrative expenses
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	4	12.7
Commodity derivative contracts \| Cost of product sold
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	14.6	(34.7)
Cash flow hedging
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	26.1	79.9
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	39.2	26.2
Cash flow hedging \| Foreign currency contracts
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	26.1	79.3
Cash flow hedging \| Foreign currency contracts \| Sales
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	0.1	0
Cash flow hedging \| Foreign currency contracts \| Cost of product sold
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	$ 39.1	26.4
Cash flow hedging \| Pre-issuance hedge contracts
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI		0.6
Cash flow hedging \| Pre-issuance hedge contracts \| Interest expense, net
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)		$ (0.2)

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Debt and Investments (Details) - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion	$ 11,089.1	$ 11,637.9
Carrying amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion	11,089.1	11,637.9
Fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion	$ 10,176.1	$ 10,775.8

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Recurring Basis Measurements (Details) - Recurring - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024
Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	$ 291.7	$ 311.2
Derivative liability	6.8	5.4
Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	16.9	6.2
Derivative liability	23.6	36
Quoted Prices in Active Markets (Level 1) \| Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0	0
Derivative liability	0	0
Quoted Prices in Active Markets (Level 1) \| Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0	0
Derivative liability	0	0
Significant Other Observable Inputs (Level 2) \| Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	291.7	311.2
Derivative liability	6.8	5.4
Significant Other Observable Inputs (Level 2) \| Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	16.9	6.2
Derivative liability	23.6	36
Significant Unobservable Inputs (Level 3) \| Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0	0
Derivative liability	0	0
Significant Unobservable Inputs (Level 3) \| Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0	0
Derivative liability	$ 0	$ 0

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Nonrecurring Basis Measurements (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2024	May 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, total losses	$ 0	$ 123.5
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, total losses		123.5
Nonrecurring \| Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments		142.7
Nonrecurring \| Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments		0
Nonrecurring \| Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments		$ 0

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Impairment of Equity Method Investments and Long-Lived Assets (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2024	May 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, total losses	$ 0	$ 123.5
Canopy Equity Method Investment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, carrying value		266.2
Equity method investments		142.7
Equity method investments, total losses		$ 123.5

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
Goodwill (Details) - USD ($) $ in Millions	Jun. 30, 2024	May 31, 2024	Feb. 29, 2024
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period	$ 7,985.4	$ 7,980.3	$ 7,925.4
Purchase accounting allocations			6.5
Foreign currency translation adjustments		5.1	48.4
Goodwill, end of period		7,985.4	7,980.3
Operating Segments \| Beer
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period	5,242.6	5,238.2	5,188.9
Purchase accounting allocations			0
Foreign currency translation adjustments		4.4	49.3
Goodwill, end of period		5,242.6	5,238.2
Operating Segments \| Wine and Spirits
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period	2,742.8	2,742.1	2,736.5
Purchase accounting allocations			6.5
Foreign currency translation adjustments		0.7	(0.9)
Goodwill, end of period		$ 2,742.8	$ 2,742.1
Operating Segments \| Wine and Spirits \| Sea Smoke Business Acquisition \| Subsequent Event
Changes in the carrying amount of goodwill [Roll Forward]
Purchase price	$ 170

Intangible Assets - Component o

Intangible Assets - Component of Intangible Assets (Details) - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	$ 106.2	$ 106.1
Amortizable intangible assets, Net Carrying Amount	16.1	16.5
Indefinite-lived Intangible Assets [Line Items]
Intangible assets	2,731.5	2,731.7
Trademarks
Indefinite-lived Intangible Assets [Line Items]
Nonamortizable intangible assets, Net Carrying Amount	2,715.4	2,715.2
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	85.4	85.3
Amortizable intangible assets, Net Carrying Amount	15.8	16.2
Other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	20.8	20.8
Amortizable intangible assets, Net Carrying Amount	$ 0.3	$ 0.3

Other Assets Components (Detail

Other Assets Components (Details) - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024	May 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Operating lease right-of-use asset	$ 606.2	$ 615.3
Derivative assets	146.7	154.9
Equity method investments	126.9	170.6	$ 291.3
Exchangeable Shares	97.3	0
Other investments in debt and equity securities	86	73
Assets held for sale	26.1	25.7
Other	107.3	100.5
Other assets	$ 1,196.5	$ 1,140

Equity Method Investments Compo

Equity Method Investments Components (Details) - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024	May 31, 2023
Schedule of Equity Method Investments [Line Items]
Equity method investments	$ 126.9	$ 170.6	$ 291.3
Canopy Equity Method Investment
Schedule of Equity Method Investments [Line Items]
Equity method investments	0	42.5
Other equity method investments
Schedule of Equity Method Investments [Line Items]
Equity method investments	$ 126.9	$ 128.1

Exchangeable Shares (Details)

Exchangeable Shares (Details) shares in Millions, $ in Millions	1 Months Ended	3 Months Ended
	Apr. 30, 2024 CAD ($) shares	May 31, 2024 USD ($) shares	May 31, 2023 USD ($)	Apr. 01, 2024 shares	Apr. 30, 2023 CAD ($)
Schedule of Equity Method Investments [Line Items]
Net gain on conversion and exchange to Exchangeable Shares		$ 83.3	$ 0
2023 Canopy Promissory Note \| Unsecured debt
Schedule of Equity Method Investments [Line Items]
Principal amount converted to Exchangeable Shares	$ 81,200,000
Aggregate principal amount					$ 100,000,000
Interest rates of 2023 Canopy Promissory Note					4.25%
Canopy
Schedule of Equity Method Investments [Line Items]
Shares issued in promissory note exchange (in shares) \| shares	9.1
Interest in Canopy (in shares) \| shares		26.3
Net gain on conversion and exchange to Exchangeable Shares		$ 83.3	$ 0
Canopy Equity Method Investment
Schedule of Equity Method Investments [Line Items]
Equity method investment (in shares) \| shares				17.1

Borrowings - Schedule of Borrow

Borrowings - Schedule of Borrowings (Details) - USD ($) $ in Millions	May 31, 2024	Feb. 29, 2024
Schedule of Debt [Line Items]
Short-term borrowings	$ 793.2	$ 241.4
Long-term Debt
Other, current	6.5
Other, long-term	9.2
Other, total	15.7	17.8
Long-term debt, current	406.2	956.8
Long-term debt, long-term	10,682.9	10,681.1
Long-term debt, total	11,089.1	11,637.9
Unsecured debt \| Senior notes
Long-term Debt
Unsecured debt, current	399.7
Unsecured debt, long-term	10,673.7
Unsecured debt, total	11,073.4	11,620.1
Commercial paper
Schedule of Debt [Line Items]
Short-term borrowings	$ 793.2	$ 241.4

Borrowings - Credit Agreements

Borrowings - Credit Agreements (Details) - USD ($)	May 31, 2024	Feb. 29, 2024
Schedule of Debt [Line Items]
Short-term borrowings	$ 793,200,000	$ 241,400,000
Outstanding commercial paper	11,165,700,000
Revolving credit facility
Schedule of Debt [Line Items]
Short-term borrowings	$ 0	$ 0
Weighted average interest rate	0%	0%
Remaining borrowing capacity	$ 1,443,100,000	$ 1,997,000,000
Aggregate principal amount	$ 2,250,000,000
Revolving credit facility \| SOFR
Schedule of Debt [Line Items]
SOFR margin	0%	0%
Letters of credit
Schedule of Debt [Line Items]
Outstanding letters of credit	$ 11,400,000	$ 11,500,000
Aggregate principal amount	200,000,000
Commercial paper
Schedule of Debt [Line Items]
Short-term borrowings	$ 793,200,000	$ 241,400,000
Weighted average interest rate	5.70%	5.70%
Outstanding commercial paper	$ 795,500,000	$ 241,500,000
Aggregate principal amount	$ 2,250,000,000

Borrowings - Commercial Paper P

Borrowings - Commercial Paper Program (Details) - USD ($)	3 Months Ended	12 Months Ended
Borrowings - Commercial Paper Program (Details) - USD ($)	May 31, 2024	Feb. 29, 2024
Schedule of Debt [Line Items]
Outstanding borrowings	$ 793,200,000	$ 241,400,000
Commercial paper
Schedule of Debt [Line Items]
Aggregate principal amount	2,250,000,000
Outstanding borrowings	$ 793,200,000	$ 241,400,000
Weighted average interest rate	5.70%	5.70%
Weighted average remaining term	20 days	4 days

Borrowings - Debt Payments (Det

Borrowings - Debt Payments (Details) $ in Millions	May 31, 2024 USD ($)
Debt Disclosure [Abstract]
Unamortized debt issuance costs, long-term debt obligations	$ 53.8
Unamortized discount, long-term debt obligations	22.8
Fiscal 2025	405.3
Fiscal 2026	1,404.9
Fiscal 2027	603.8
Fiscal 2028	1,801.5
Fiscal 2029	900.1
Fiscal 2030	800
Thereafter	5,250.1
Total long-term debt, gross	$ 11,165.7

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended
Income Taxes (Details)	May 31, 2024	May 31, 2023
Income Tax Disclosure [Abstract]
Effective tax rate	3%	39.60%

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Common Stock and Treasury Stock Issued (Details) - shares	3 Months Ended
	May 31, 2024	May 31, 2023
Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	212,698,298
Treasury Stock, beginning of period (in shares)	29,809,881
Number of shares repurchased (in shares)	775,334
Common Stock, end of period (in shares)	212,698,298
Treasury Stock, end of period (in shares)	30,341,484
Common Stock \| Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	212,698,298	212,697,428
Conversion of shares (in shares)		80
Common Stock, end of period (in shares)	212,698,298	212,697,508
Common Stock \| Class 1 Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	23,661	22,705
Exercise of stock options (in shares)	1,880	800
Conversion of shares (in shares)		80
Common Stock, end of period (in shares)	25,541	23,425
Class A Stock in Treasury \| Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, beginning of period (in shares)	29,809,881	29,498,426
Number of shares repurchased (in shares)	775,334	153,937
Exercise of stock options (in shares)	149,324	129,595
Treasury Stock, end of period (in shares)	30,341,484	29,438,466
Class A Stock in Treasury \| Class A Stock \| Restricted stock units
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock units (in shares)	(85,650)	(71,189)
Shares withheld to satisfy tax withholding requirements (in shares)	48,501	39,839
Class A Stock in Treasury \| Class A Stock \| Performance share units
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock units (in shares)	(8,757)	(13,113)
Shares withheld to satisfy tax withholding requirements (in shares)	5,728	8,735

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) - USD ($)	1 Months Ended	3 Months Ended		8 Months Ended	42 Months Ended
Stockholders' Equity - Narrative (Details) - USD ($)	Jul. 03, 2024	May 31, 2024	May 31, 2023	Jul. 03, 2024	Jul. 03, 2024	Nov. 30, 2023	Jan. 31, 2021
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased		$ 200,000,000	$ 35,000,000
2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization							$ 2,000,000,000
2023 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization						$ 2,000,000,000
Class A Stock
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares)		775,334
Dollar Value of Shares Repurchased		$ 200,000,000
Class A Stock \| 2021 Authorization \| Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares)	187,843				6,838,453
Dollar Value of Shares Repurchased	$ 47,000,000				$ 1,633,300,000
Class A Stock \| 2023 Authorization \| Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares)				0
Dollar Value of Shares Repurchased				$ 0

Stockholders' Equity - Stock Re

Stockholders' Equity - Stock Repurchases (Details) - USD ($)	1 Months Ended	3 Months Ended		8 Months Ended	42 Months Ended
	Jul. 03, 2024	May 31, 2024	May 31, 2023	Jul. 03, 2024	Jul. 03, 2024	Nov. 30, 2023	Jan. 31, 2021
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased		$ 200,000,000	$ 35,000,000
2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization							$ 2,000,000,000
2023 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization						$ 2,000,000,000
Class A Stock
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased		$ 200,000,000
Number of shares repurchased (in shares)		775,334
Class A Stock \| Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 2,366,700,000			$ 2,366,700,000	$ 2,366,700,000
Class A Stock \| 2021 Authorization \| Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased	$ 47,000,000				$ 1,633,300,000
Number of shares repurchased (in shares)	187,843				6,838,453
Class A Stock \| 2023 Authorization \| Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased				$ 0
Number of shares repurchased (in shares)				0

Net Income (Loss) Per Common _3

Net Income (Loss) Per Common Share Attributable to CBI (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	May 31, 2024	May 31, 2023
Earnings per share reconciliation
Net income (loss) attributable to CBI	$ 877	$ 135.9
Class A Stock
Earnings per share reconciliation
Net income (loss) attributable to CBI	$ 877	$ 135.9
Weighted average number of shares outstanding reconciliation
Weighted average common shares outstanding - basic (in shares)	182,766	183,270
Stock-based awards, primarily stock options (in shares)	695	593
Weighted average common shares outstanding - diluted (in shares)	183,461	183,863
Basic and diluted net income (loss) per common share attributable to CBI
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 4.80	$ 0.74
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 4.78	$ 0.74

Comprehensive Income (Loss) A_3

Comprehensive Income (Loss) Attributable to CBI - Reconciliation of Net Income (Loss) Attributable to CBI to Comprehensive Income (Loss) Attributable to CBI (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2024	May 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net income (loss) attributable to CBI	$ 877	$ 135.9
Other comprehensive income (loss) attributable to CBI
Other comprehensive income (loss) attributable to CBI, net of tax amount	(8.7)	225.3
Comprehensive income (loss) attributable to CBI	868	350.3
Accumulated Other Comprehensive Income (Loss)
Other comprehensive income (loss) attributable to CBI
Net gain (loss), net of tax amount	38.4
Reclassification adjustments, net of tax amount	(47.4)
Other comprehensive income (loss) attributable to CBI, before tax amount	(10.7)	221.4
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	1.7	(7)
Other comprehensive income (loss) attributable to CBI, net of tax amount	(9)	214.4
Accumulated Other Comprehensive Income (Loss) \| Share of OCI of Equity Method Investments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	0	(0.3)
Net gain (loss), tax (expense) benefit	0	0.1
Net gain (loss), net of tax amount	0	(0.2)
Reclassification adjustments, before tax amount	(10.3)	0
Reclassification adjustments, tax (expense) benefit	0	0
Reclassification adjustments, net of tax amount	(10.3)	0
Other comprehensive income (loss) attributable to CBI, before tax amount	(10.3)	(0.3)
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	0	0.1
Other comprehensive income (loss) attributable to CBI, net of tax amount	(10.3)	(0.2)
Foreign Currency Translation Adjustments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	13.5	163.4
Net gain (loss), tax (expense) benefit	0	0
Net gain (loss), net of tax amount	13.5	163.4
Reclassification adjustments, before tax amount	0	0
Reclassification adjustments, tax (expense) benefit	0	0
Reclassification adjustments, net of tax amount	0	0
Other comprehensive income (loss) attributable to CBI, before tax amount	13.5	163.4
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	13.5	163.4
Unrealized Net Gain (Loss) on Derivative Instruments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	28.2	86.4
Net gain (loss), tax (expense) benefit	(3.3)	(10.4)
Net gain (loss), net of tax amount	24.9	76
Reclassification adjustments, before tax amount	(42.1)	(27.8)
Reclassification adjustments, tax (expense) benefit	5	3.2
Reclassification adjustments, net of tax amount	(37.1)	(24.6)
Other comprehensive income (loss) attributable to CBI, before tax amount	(13.9)	58.6
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	1.7	(7.2)
Other comprehensive income (loss) attributable to CBI, net of tax amount	(12.2)	51.4
Pension/ Postretirement Adjustments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount		(0.3)
Net gain (loss), tax (expense) benefit		0.1
Net gain (loss), net of tax amount	0	(0.2)
Reclassification adjustments, before tax amount		0
Reclassification adjustments, tax (expense) benefit		0
Reclassification adjustments, net of tax amount	0	0
Other comprehensive income (loss) attributable to CBI, before tax amount		(0.3)
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit		0.1
Other comprehensive income (loss) attributable to CBI, net of tax amount	$ 0	$ (0.2)

Comprehensive Income (Loss) A_4

Comprehensive Income (Loss) Attributable to CBI - Accumulated Other Comprehensive Income (Loss), Net of Income Tax Effect (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2024	May 31, 2023
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period	$ 9,743.1
Other comprehensive income (loss):
Other comprehensive income (loss) attributable to CBI, net of tax amount	(8.7)	$ 225.3
Stockholders' equity, period end	10,251.8
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period	376.8
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	38.4
Amounts reclassified from accumulated other comprehensive income (loss)	(47.4)
Other comprehensive income (loss) attributable to CBI, net of tax amount	(9)	214.4
Stockholders' equity, period end	367.8
Accumulated Other Comprehensive Income (Loss) \| Share of OCI of Equity Method Investments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period	10.3
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	0	(0.2)
Amounts reclassified from accumulated other comprehensive income (loss)	(10.3)	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	(10.3)	(0.2)
Stockholders' equity, period end	0
Foreign Currency Translation Adjustments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period	102.9
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	13.5	163.4
Amounts reclassified from accumulated other comprehensive income (loss)	0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	13.5	163.4
Stockholders' equity, period end	116.4
Unrealized Net Gain (Loss) on Derivative Instruments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period	266.2
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	24.9	76
Amounts reclassified from accumulated other comprehensive income (loss)	(37.1)	(24.6)
Other comprehensive income (loss) attributable to CBI, net of tax amount	(12.2)	51.4
Stockholders' equity, period end	254
Pension/ Postretirement Adjustments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period	(2.6)
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	0	(0.2)
Amounts reclassified from accumulated other comprehensive income (loss)	0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	0	$ (0.2)
Stockholders' equity, period end	$ (2.6)

Business Segment Information -

Business Segment Information - Narrative (Details)	3 Months Ended
Business Segment Information - Narrative (Details)	May 31, 2024 division segment
Segment Reporting [Abstract]
Number of business divisions \| division	2
Number of reportable operating segments \| segment	3

Business Segment Information _2

Business Segment Information - Comparable Adjustments (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2024	May 31, 2023
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	$ 18.6	$ (22)
Comparable Adjustments, Cost of product sold	(1,258)	(1,257.1)
Selling, general, and administrative expenses
Comparable Adjustments, Selling, general, and administrative expenses	(462.2)	(493.1)
Comparable Adjustments
Cost of product sold
Flow through of inventory step-up	(1.1)	(0.7)
Comparable Adjustments, Cost of product sold	22	(34.8)
Selling, general, and administrative expenses
Transition services agreements activity	(2.8)	(5.7)
Restructuring and other strategic business development costs	(1.8)	(14.9)
Transaction, integration, and other acquisition-related costs	(0.2)	(0.3)
Other gains (losses)	0.4	(6.8)
Comparable Adjustments, Selling, general, and administrative expenses	(4.4)	(27.7)
Comparable Adjustments, Operating income (loss)	17.6	(62.5)
Gain (loss) on sale of business	0	(7)
Comparable Adjustments \| Commodity derivative contracts
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	14.6	(34.7)
Settlements of undesignated commodity derivative contracts	$ 8.5	$ 0.6

Business Segment Information _3

Business Segment Information - Segment Information (Details) - USD ($)	3 Months Ended
	May 31, 2024	May 31, 2023	Feb. 29, 2024
Segment Reporting Information [Line Items]
Net sales	$ 2,661,800,000	$ 2,514,900,000
Segment operating income (loss)	941,600,000	764,700,000
Income (loss) from unconsolidated investments	82,000,000	(415,400,000)
Equity method investments	126,900,000	291,300,000	$ 170,600,000
Capital expenditures	375,300,000	277,000,000
Depreciation and amortization	111,900,000	105,700,000
Income (loss) from unconsolidated investments
Net gain on conversion and exchange to Exchangeable Shares	83,300,000	0
Impairment of equity method investments	0	(123,500,000)
Unrealized net (gain) loss on securities measured at fair value	0	(71,800,000)
Income (loss) from unconsolidated investments	82,000,000	(415,400,000)
2023 Canopy Promissory Note
Income (loss) from unconsolidated investments
Fair value of warrants		0
Other equity method investments
Segment Reporting Information [Line Items]
Equity method investments	126,900,000		128,100,000
Income (loss) from unconsolidated investments
Equity in earnings (losses) of equity method investees and related activities	(1,300,000)	(300,000)
Canopy Equity Method Investment
Segment Reporting Information [Line Items]
Equity method investments	0		$ 42,500,000
Income (loss) from unconsolidated investments
Equity in earnings (losses) of equity method investees and related activities	0	(219,800,000)
Impairment of equity method investments		(123,500,000)
Canopy
Income (loss) from unconsolidated investments
Net gain on conversion and exchange to Exchangeable Shares	83,300,000	0
Operating Segments \| Beer
Segment Reporting Information [Line Items]
Net sales	2,272,800,000	2,098,600,000
Segment operating income (loss)	923,000,000	797,800,000
Capital expenditures	314,400,000	205,600,000
Depreciation and amortization	86,400,000	78,800,000
Operating Segments \| Wine and Spirits
Segment Reporting Information [Line Items]
Net sales	389,000,000	416,300,000
Segment operating income (loss)	59,700,000	79,300,000
Income (loss) from unconsolidated investments	400,000	2,300,000
Equity method investments	101,200,000	96,800,000
Capital expenditures	49,600,000	38,600,000
Depreciation and amortization	21,300,000	22,500,000
Income (loss) from unconsolidated investments
Income (loss) from unconsolidated investments	400,000	2,300,000
Operating Segments \| Wine and Spirits \| Wine
Segment Reporting Information [Line Items]
Net sales	329,300,000	361,000,000
Operating Segments \| Wine and Spirits \| Spirits
Segment Reporting Information [Line Items]
Net sales	59,700,000	55,300,000
Operating Segments \| Corporate Operations and Other
Segment Reporting Information [Line Items]
Segment operating income (loss)	(58,700,000)	(49,900,000)
Income (loss) from unconsolidated investments	(1,700,000)	(33,300,000)
Equity method investments	25,700,000	194,500,000
Capital expenditures	11,300,000	32,800,000
Depreciation and amortization	4,200,000	4,400,000
Income (loss) from unconsolidated investments
Income (loss) from unconsolidated investments	(1,700,000)	(33,300,000)
Comparable Adjustments
Segment Reporting Information [Line Items]
Segment operating income (loss)	17,600,000	(62,500,000)
Income (loss) from unconsolidated investments	83,300,000	(384,400,000)
Income (loss) from unconsolidated investments
Income (loss) from unconsolidated investments	$ 83,300,000	$ (384,400,000)